Picture EBD Group BioTech Showcase 2022 Present Your Innovations 650x100

News > All

Please find below news from the Benelux countries (Belgium, Luxembourg and The Netherlands) as well as about organisations from these countries.

Total search results: 1481 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Malvern Panalytical B.V.. (1/14/22). "Press Release: Malvern Panalytical Inc. and TA Instruments-Waters LLC Agree to Partial Settlement of Patent Infringement Lawsuit". Almelo. 2022-01-14
Lumicks Technologies B.V.. (1/12/22). "Press Release: Lumicks Announces the Installation of its Quadruple C-Trap® Instrument at Rockefeller University to Expand Fundamental Research of DNA Processes". Amsterdam. 2022-01-12
Cato SMS. (1/5/22). "Press Release: Cato SMS and Pharm-Olam Merge to Create Global Biopharmaceutical Services Leader". Cary, NC & Bracknell. 2022-01-05
Antigon S.A.. (12/22/21). "Press Release: Antigon Raises €1.5m to CE Mark Portable Blood Transfusion Security Device ISABO". Gosselies. 2021-12-22
Thuja Capital Management. (12/21/21). "Press Release: Thuja Announces the Final Close of Thuja Capital Healthcare Fund III at EUR 76M (USD 86M)". Utrecht. 2021-12-21
Argenx SE. (12/20/21). "Press Release: Argenx Announces U.S. Food and Drug Administration (FDA) Approval of Vyvgart (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis". Darmstadt. 2021-12-20
NorthSea Therapeutics B.V.. (12/17/21). "Press Release: NorthSea Therapeutics Completes US$80 Million Series C Fundraising to Advance Clinical Programs in Metabolic Disorders". Amsterdam. 2021-12-17
Synerkine Pharma B.V.. (12/16/21). "Press Release: Synerkine Pharma Raises EUR 3.5 Million in an Extended Series A Financing". Naarden. 2021-12-16
Anaveon AG. (12/16/21). "Press Release: Anaveon to Raise CHF 110 Million in Oversubscribed Series B Financing". Basel. 2021-12-16
Metrion Biosciences Ltd.. (12/16/21). "Press Release: Metrion Biosciences and Bioqube Ventures Collaborate on Venture Creation Project to Identify novel ion channel inhibitors for autoimmune diseases". Cambridge & Brussels. 2021-12-16
Argobio S.A.S.. (12/16/21). "Press Release: Argobio and GeneCode Partner on Parkinson’s Disease in Argobio’s First Announced Research Agreement". Paris & Tallinn. 2021-12-16
CellCarta. (12/14/21). "Press Release: CellCarta Acquires Biogazelle to Strengthen Its Genomic Capabilities and Expand into Digital PCR (dPCR) Services". Montréal. 2021-12-14
Gilde Healthcare Partners. (12/14/21). "Press Release: Philips Acquires Gilde Portfolio Company Vesper Medical to Further Expand Its Image-guided Therapy Devices Portfolio". Amsterdam & Utrecht. 2021-12-14
Sirius Medical Systems B.V.. (12/14/21). "Press Release: Sirius Medical Announces Second Closing of A-Round Financing". 2021-12-14
Wacker Chemie AG. (12/14/21). "Press Release: Wacker and CordenPharma Develop Solutions for Formulating Lipid Nanoparticles Expanding Their Portfolio for Advanced Medicines". Munich & Luxembourg. 2021-12-14
Ryvu Therapeutics S.A.. (12/14/21). "Press Release: Ryvu Announces Option to License Inflammation Program Exercised by Galapagos NV". Tübingen, Houston, TX & New York, NY. 2021-12-14
Forbion Capital Partners. (12/9/21). "Press Release: Forbion European Acquisition Corp. Announces Pricing of $110 Million Initial Public Offering". Naarden. 2021-12-09
Corteria Pharmaceuticals S.A.S.. (12/9/21). "Press Release: Corteria Pharmaceuticals Announces Closing of €12M Seed Financing to Advance Portfolio Assets". Paris. 2021-12-09
Anavo Therapeutics B.V.. (12/9/21). "Press Release: Anavo Therapeutics Announces the Appointment of Charles McDermott as Chairman of the Board". Leiden & Heidelberg. 2021-12-09
Uniqure N.V.. (12/9/21). "Press Release: Uniqure and CSL Behring Announce Primary Endpoint Achieved in HOPE-B Pivotal Trial of Etranacogene Dezaparvovec Gene Therapy in Patients with Hemophilia B". Lexington, MA, Amsterdam & King of Prussia, PA. 2021-12-09
Merck KGaA. (12/8/21). "Press Release: Merck Expands Corporate Venture Fund M Ventures with a New Investment of € 600 Million". Darmstadt. 2021-12-08
AdBio Partners S.A.S.. (12/7/21). "Press Release: Advent France Biotechnology Becomes AdBio Partners". Paris. 2021-12-07
HypnoVR S.A.S.. (12/7/21). "Press Release: HypnoVR Raises €4.5 Million to Accelerate the Roll Out of Its Digital Therapy Treating Pain and Anxiety". Strasbourg. 2021-12-07
AviadoBio Ltd.. (12/2/21). "Press Release: AviadoBio Raises $80 million in Series A Financing to Advance Neurodegenerative Gene Therapy Platform". London. 2021-12-02
Sotio Biotech a.s.. (12/2/21). "Press Release: Sotio Secures €280m of Funding to Expand and Advance Clinical Pipeline". Prague, Basel & Cambridge, MA. 2021-12-02
Ona Therapeutics. (12/2/21). "Press Release: Ona Therapeutics Appoints Dr Michel Detheux as Independent Chair to Board of Directors". Barcelona. 2021-12-02
UCB S.A.. (12/2/21). "Press Release: UCB Announces Global Partnership to Bring Disease-modifying Therapies to People Living with Parkinson’s Disease". Brussels. 2021-12-02
Amarna Therapeutics B.V.. (12/1/21). "Press Release: Amarna Therapeutics Secures Additional €5 ($5.7) Million to Advance Its Transformative Gene Therapy Platform towards Clinical Trials". Leiden. 2021-12-01
UCB S.A.. (11/30/21). "Press Release: UCB and Chiesi Enter Global License Agreement for Zampilimab a Novel Monoclonal Antibody for Fibrotic Lung Diseases". Brussels & Parma. 2021-11-30
HotSpot Therapeutics, Inc.. (11/29/21). "Press Release: HotSpot Therapeutics Closes $100M Series C to Advance First-in-Class Allosteric Drug Discovery Platform to the Clinic". Boston, MA. 2021-11-29
Centogene N.V.. (11/24/21). "Press Release: Centogene Reports Third Quarter 2021 Financial Results". Cambridge, MA, Rostock & Berlin. 2021-11-24
Bruker Corporation. (11/19/21). "Press Release: Bruker Announces Acquisition of Molecubes NV". Ghent. 2021-11-19
Euronext N.V.. (11/18/21). "Press Release: European Healthcare Acquisition & Growth Company B.V (EHC) Lists on Euronext Amsterdam". Amsterdam. 2021-11-18
Sotio Biotech a.s.. (11/16/21). "Press Release: Sotio Expands Its Antibody-Drug Conjugate Pipeline with Exclusive Collaboration and License Agreement with LegoChem Biosciences". Prague. 2021-11-16
Mainz Biomed N.V.. (11/11/21). "Press Release: Mainz Biomed Appoints Former Roche Division President Heiner Dreismann to Strategic Advisory Board". Berkeley, CA & Mainz. 2021-11-11
EQT AB. (11/10/21). "Press Release: EQT Strengthens Position in Healthcare Investments by Joining Forces with LSP". 2021-11-10
Mainz Biomed N.V.. (11/8/21). "Press Release: Mainz Biomed Commences Trading on Nasdaq Under Ticker Symbol ‘MYNZ’". Berkeley, CA & Mainz. 2021-11-08
Mainz Biomed N.V.. (11/5/21). "Press Release: MYNZ Shares Have Commenced Trading on the Nasdaq Capital Market". Berkeley, CA & Mainz. 2021-11-05
Life Sciences Partners (LSP). (11/4/21). "Press Release: LSP Raises Record $1 Billion for Its 7th Flagship Life Sciences Fund". Amsterdam. 2021-11-04
MDxHealth S.A.. (11/4/21). "Press Release: MDxHealth Announces Pricing of Initial Public Offering of ADSs in the United States". Irvine, CA & Herstal. 2021-11-04
Dunad Therapeutics. (11/2/21). "Press Release: Dunad Therapeutics Enters Strategic Collaboration with Novartis". Cambridge. 2021-11-02
Pan Cancer T B.V.. (10/28/21). "Press Release: Pan Cancer T Extends Seed Financing Round with Additional Funding from Existing Shareholders and New Investor Thuja Capital". Rotterdam. 2021-10-28
Agomab Therapeutics N.V.. (10/28/21). "Press Release: Agomab Therapeutics to Acquire Origo Biopharma". Ghent. 2021-10-28
MDxHealth S.A.. (10/28/21). "Press Release: MDxHealth Announces Launch of Proposed Initial Public Offering of ADSs in the United States". Irvine, CA & Herstal. 2021-10-28
Noxxon Pharma N.V.. (10/27/21). "Press Release: Experienced Financial Executive, Bryan Jennings, Joins Noxxon as CFO". Berlin. 2021-10-27
DNA Script. (10/26/21). "Press Release: DNA Script Raises $165M in Oversubscribed Series C Financing to Accelerate Commercialization of Enzymatic DNA Printing Platform". South San Francisco, CA & Paris. 2021-10-26
TrueMass. (10/26/21). "Press Release: True Mass Presents First Commercial CDMS Instrument to Support Analysis of Macromolecules". 2021-10-26
Immunicum AB. (10/26/21). "Press Release: Immunicum Appoints Lotta Ferm as Chief Financial Officer". 2021-10-26
Egle Therapeutics S.A.S.. (10/22/21). "Press Release: Egle Therapeutics Raises 40 million € Series A to Develop First-In-Class T-regulatory Cells Therapies Based on Treg-starvers". Paris. 2021-10-22
Biotalys N.V.. (10/20/21). "Press Release: Biotalys Awarded Multi-Year Grant to Develop New Biological Solutions for Cowpea and Other Legumes". Ghent & Research Triangle Park, NC. 2021-10-20
InflaRx N.V.. (10/19/21). "Press Release: InflaRx Awarded up to EUR 43.7 Million (~USD 50.7 Million) Grant by German Government to Advance the Development of Vilobelimab for Treatment of Severe COVID-19". Jena. 2021-10-19
Sofinnova Partners. (10/19/21). "Press Release: Sofinnova Partners Raises €472 ($548) Million to Form Largest Early-stage Healthcare VC Fund in Europe". Paris. 2021-10-19
Eurofins Scientific SE. (10/14/21). "Press Release: $30m Contract for Expanded Oligo Capacity". 2021-10-14
Rectify Pharmaceuticals, Inc.. (10/14/21). "Press Release: Rectify Pharmaceuticals Launches with $100 Million Series A Financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund". Cambridge, MA. 2021-10-14
Forbion Capital Partners. (10/14/21). "Press Release: Forbion Co-leads New Investment in Rectify Pharmaceuticals Which Launches with $100m Series A Financing". Cambridge, MA. 2021-10-14
Demy-Colton Inc.. (10/14/21). "Press Release: BioFuture Conference 2021 Launch in New York City Inspires Innovation Across Life Sciences and Digital Health". New York, NY. 2021-10-14
CureVac N.V.. (10/12/21). "Press Release: CureVac to Shift Focus of COVID-19 Vaccine Development to Second-Generation mRNA Technology". Tübingen & Boston, MA. 2021-10-12
iOmx Therapeutics AG. (10/5/21). "Press Release: iOmx Therapeutics Raises EUR 65 Million in Series B Round". Martinsried. 2021-10-05
Atbtherapeutics. (10/5/21). "Press Release: Atbtherapeutics Expands Leadership Team and Scientific Advisory Board with Pharmaceutical Industry Experts". Aye. 2021-10-05
Advent France Biotechnology S.A.S.. (9/30/21). "Press Release: Advent France Biotechnology Launches Its Second Fund with a First Close at €86M ($102M)". Paris. 2021-09-30
Biotalys N.V.. (9/30/21). "Press Release: Biotalys Strengthens Executive Team with the Appointment of Patrick McDonnell as Chief Business Officer". Ghent & Research Triangle Park, NC. 2021-09-30
Draupnir Bio ApS. (9/23/21). "Press Release: Draupnir Bio Establishes Scientific Advisory Board of International Experts in Cholesterol Metabolism and Cardiovascular Disease". Copenhagen. 2021-09-23
Thermo Fisher Scientific Inc.. (9/23/21). "Press Release: Thermo Fisher Scientific Opens Biologics Manufacturing Site in Lengnau, Switzerland". Bremen. 2021-09-23
Novo Nordisk Foundation. (9/22/21). "Press Release: New Research Center Will Find Solutions to Reduce CO2 in the Atmosphere and Convert it into Valuable Raw Materials". 2021-09-22
Jeito Capital. (9/20/21). "Press Release: Jeito Capital Becomes Key Player in the Financing of Life Sciences in Europe with the Closing of Jeito I at €534 million ($630 million)". Paris. 2021-09-20
Anjarium Biosciences AG. (9/16/21). "Press Release: Anjarium Biosciences Raises CHF 55.5M ($61M) Series A Financing to Develop Next-Generation Non-viral Gene Therapies". Schlieren. 2021-09-16
Oxitope Pharma B.V.. (9/16/21). "Press Release: Launch of Oxitope Pharma, a Biopharmaceutical Start-up Dedicated to the Discovery and Development of Antibody-based Medicines for the Treatment of Diseases Caused by Oxidative Stress". Amsterdam. 2021-09-16
Forbion Capital Partners. (9/16/21). "Press Release: Forbion Launches Portfolio Company Oxitope Pharma Focused on Inflammatory, Cardiovascular and Fibrotic Diseases". Naarden. 2021-09-16
CureVac N.V.. (9/14/21). "Press Release: CureVac Streamlines European Network for mRNA Product Manufacturing". Tübingen & Boston, MA. 2021-09-14
BioGeneration Ventures B.V.. (9/14/21). "Press Release: BGV Expands Team with the Appointment of a Partner and Venture Partner". Naarden. 2021-09-14
Meatable. (9/13/21). "Press Release: Meatable Enters into Joint Development Agreement with Royal DSM to Develop Affordable Growth Media for Cultivated Meat". Amsterdam. 2021-09-13
Argenx SE. (9/3/21). "Press Release: Argenx to Present at Upcoming Investor Conferences". Breda. 2021-09-03
Forbion Capital Partners. (9/1/21). "Press Release: Forbion Appoints Nanna Lüneborg as a General Partner". Naarden. 2021-09-01
CureVac N.V.. (8/31/21). "Press Release: CureVac’s CVnCoV Phase 2b/3 Study Data Published in Preprints with The Lancet". Tübingen & Boston, MA. 2021-08-31
Galapagos N.V.. (8/30/21). "Press Release: Galapagos Announces Planned Retirement of CEO". Mechelen. 2021-08-30
CureVac N.V.. (8/30/21). "Press Release: CureVac Preclinical Data Demonstrates Significant Reduction of Liver Fibrosis with mRNA Therapeutic". Tübingen & Boston, MA. 2021-08-30
Cardior Pharmaceuticals GmbH. (8/25/21). "Press Release: Cardior Raises €64 M Series B to Advance Clinical Pipeline of RNA Therapeutics to Treat Cardiac Disease". Hanover. 2021-08-25
Insilico Biotechnology AG. (8/24/21). "Press Release: Insilico Biotechnology AG Participates in Inno4vac, a European new public-private partnership to innovate vaccine development". Stuttgart. 2021-08-24
Atlas Antibodies AB. (8/20/21). "Press Release: Atlas Antibodies AB Appoints Nille Klæbel as New CEO". 2021-08-20
Bristol-Myers Squibb Company. (8/19/21). "Press Release: Bristol Myers Squibb Receives European Commission Approval for Abecma (Idecabtagene Vicleucel), the First Anti-BCMA CAR T Cell Therapy for Relapsed and Refractory Multiple Myeloma". Princeton, NJ. 2021-08-19
Lumicks Technologies B.V.. (8/17/21). "Press Release: Lumicks Appoints Paul Wheeler to Leadership Team as Chief Commercial Officer to Drive New Business Growth". Amsterdam. 2021-08-17
Anavo Therapeutics B.V.. (8/16/21). "Press Release: Anavo Therapeutics to Establish R&D Hub in World-Leading Cancer Research Cluster". Leiden & Heidelberg. 2021-08-16
CureVac N.V.. (8/16/21). "Press Release: CureVac Announces Financial Results for the Second Quarter and First Half of 2021 and Provides Business Update". Tübingen, Boston, MA & London. 2021-08-16
Draupnir Bio ApS. (8/12/21). "Press Release: Draupnir Bio Expands Research Operations with New Facility at INCUBA Research Ppark". Copenhagen. 2021-08-12
Visus Therapeutics Inc.. (8/10/21). "Press Release: Visus Therapeutics Secures $20 Million in Additional Financing Led by New Investor LSP, with Participation from Sage Partners". Seattle, WA. 2021-08-10
Qiagen N.V.. (8/9/21). "Press Release: Qiagen and OncXerna Therapeutics Sign Licensing and Master Companion Diagnostic Agreements". Hilden, Waltham, MA & Germantown, MD. 2021-08-09
Mestag Therapeutics Ltd.. (8/3/21). "Press Release: Mestag Therapeutics Extends Seed Financing to $45 Million and Welcomes New Investors Forbion, GV (formerly Google Ventures) and Northpond Ventures". Cambridge. 2021-08-03
Spectricity B.V.. (8/3/21). "Press Release: Spectricity Raises €14 Million Series B Funding as it Accelerates Plans to Deliver Industry Leading Hyperspectral Sensing to Mobile and Consumer Devices". Mechelen. 2021-08-03
T-Knife Therapeutics, Inc.. (8/2/21). "Press Release: T-Knife Therapeutics Announces $110 Million Series B Financing to Advance Pipeline of T-cell Receptor Therapies". San Francisco, CA & Berlin. 2021-08-02
Topas Therapeutics GmbH. (7/29/21). "Press Release: Topas Therapeutics Extends Series B, Raising Total of €40 Million (~$ 48 Million) in this Round". Hamburg. 2021-07-29
SynOx Therapeutics Ltd.. (7/27/21). "Press Release: SynOx Therapeutics Strengthens Team with Appointment of Ton Logtenberg as Chairman and Ray Barlow as Chief Executive Officer". Dublin. 2021-07-27
Artios Pharma Ltd.. (7/27/21). "Press Release: Artios Announces $153 Million (£110 Million) Series C Financing Led by Omega Funds and TCG X". Cambridge & New York, NY. 2021-07-27
Glycotope GmbH. (7/27/21). "Press Release: Byondis and Glycotope Enter Platform Access Agreement for Discovery and Development of Antibodies Against Novel GlycoTargets". Nijmegen & Berlin. 2021-07-27
AXA Investment Managers. (7/26/21). "Press Release: AXA IM Alts Raises €1.9 Billion for European Life Sciences Investments". 2021-07-26
Slingshot Biosciences. (7/22/21). "Press Release: Slingshot Biosciences Announces $23 Million in Series A Financing". Emeryville, CA. 2021-07-22
Synaffix B.V.. (7/22/21). "Press Release: Synaffix Announces Deal with ProfoundBio Worth up to $246 Million Providing Access to Multiple Novel Linker-Payload Technologies". Amsterdam. 2021-07-22
Coave Therapeutics (Horama S.A.). (7/21/21). "Press Release: Coave Therapeutics Closes €33 million ($39 million) Series B Financing to Develop its Gene Therapy Pipeline and Next-Generation Vectors based on its AAV-Ligand Conjugate Platform". Paris. 2021-07-21
NanoSyrinx Ltd.. (7/19/21). "Press Release: NanoSyrinx Raises £6.2m to Develop Its Synthetic Biology Platform for Targeted Intracellular Engineering". Coventry. 2021-07-19
Argenx SE. (7/14/21). "Press Release: Argenx to Host Virtual R&D Day on July 20, 2021". Breda. 2021-07-14
Mimetas B.V.. (7/6/21). "Press Release: Mimetas and Roche Enter into a Collaboration to Develop Human Disease Models for Drug Development". Leiden. 2021-07-06
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page


Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group BioTech Showcase 2022 Present Your Innovations 650x300

» top